Combination of urinary fibrinogen β-chain and tyrosine-phosphorylated proteins for the detection of bladder cancer

AIM: To evaluate the performance of urinary fibrinogen β-chain (FBC) – either alone or associated with urinary tyrosine-phosphorylated proteins (UPY) – as bladder cancer (BCa) diagnostic biomarker. MATERIALS & METHODS: 164 subjects were tested. RESULTS: Significantly different FBC and UPY levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Giribaldi, Giuliana, Filippini, Claudia, Viberti, Clara, Khadjavi, Amina, Finesso, Nicole, Ulliers, Daniela, Turini, Stefano, Bressan, Bruno Emilio, Pecoraro, Francesca, Prato, Mauro, Allione, Alessandra, Bellis, Matteo De, Montefusco, Gabriele, Bonomessi, Giulia, Allasia, Marco, Matullo, Giuseppe, Soria, Francesco, Gontero, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558871/
https://www.ncbi.nlm.nih.gov/pubmed/34737890
http://dx.doi.org/10.2144/fsoa-2021-0060
Descripción
Sumario:AIM: To evaluate the performance of urinary fibrinogen β-chain (FBC) – either alone or associated with urinary tyrosine-phosphorylated proteins (UPY) – as bladder cancer (BCa) diagnostic biomarker. MATERIALS & METHODS: 164 subjects were tested. RESULTS: Significantly different FBC and UPY levels were found between BCa patients and controls, as well as between low-grade and high-grade cancers. The diagnostic accuracy was 0.84 for FBC and 0.87 for UPY. The combination of FBC and UPY improved the accuracy to 0.91. The addition of clinical variables (age, gender, and smoking habit) to FBC and UPY into a model for BCa prediction significantly improved the accuracy to 0.99. The combination of FBC and UPY adjusted for clinical variables associates with the highest sensitivity and good specificity. CONCLUSION: Urinary FBC and UPY could be used as biomarkers for BCa diagnosis.

Ejemplares similares